247 results on '"Rosenbaum, Andrew N."'
Search Results
2. Novel Left Ventricular Unloading Strategies in Patients on Peripheral Venoarterial Extracorporeal Membrane Oxygenation Support
3. Professional Employment With Left Ventricular Assist Device Support: Does Working With an LVAD Allow It to Work Too?
4. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis
5. Arrhythmic manifestations and outcomes of definite and probable cardiac sarcoidosis
6. Case Series: Recurrence of Cardiac Sarcoidosis After Orthotopic Heart Transplantation
7. An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic
8. Outcomes and Predictors of Mortality Among Cardiac Intensive Care Unit Patients With Heart Failure
9. Interventricular-Septal Output While Supported on Left Ventricular Assist Device Therapy
10. Pulsatile Pressure Delivery of Continuous-Flow Left Ventricular Assist Devices Is Markedly Reduced Relative to Heart Failure Patients
11. Left Ventricular Hemodynamics and Relationship With Myocardial Recovery and Optimization in Patients Supported on CF-LVAD Therapy
12. Artificial Intelligence-Enabled Electrocardiography to Screen Patients with Dilated Cardiomyopathy
13. Effect of Corticosteroid Therapy in Patients With Cardiac Sarcoidosis on Frequency of Venous Thromboembolism
14. Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients
15. Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization
16. Inhibition of angiogenesis in the management of refractory gastrointestinal bleeding in patients with LVAD support.
17. Biventricular catheterization combined with pressure‐volume loop monitoring provides insight into the dynamic effects of left ventricular assist devices ramp on right ventricular function.
18. First Report of Proton Beam Therapy in a Patient With a Left Ventricular Assist Device
19. Inhibition of angiogenesis in the management of refractory gastrointestinal bleeding in patients with LVAD support
20. Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated Inflammatory Cardiomyopathies
21. Genetics of dilated cardiomyopathy: practical implications for heart failure management
22. Paced QRS morphology predicts incident left ventricular systolic dysfunction and atrial fibrillation
23. Natural History of Patients Diagnosed with Cardiac Sarcoidosis at Left Ventricular Assist Device Implantation or Cardiac Transplantation
24. Percutaneous Axillary Intra-aortic Balloon Pump Insertion Technique as Bridge to Advanced Heart Failure Therapy
25. Correction of High Afterload Improves Low Cardiac Output in Patients Supported on Left Ventricular Assist Device Therapy
26. Outcomes of Nonagenarians Admitted to the Cardiac Intensive Care Unit by the Elders Risk Assessment Score for Long-Term Mortality Risk Stratification
27. Infections in Patients With Left Ventricular Assist Devices: Current State and Future Perspectives
28. Use of Novel Diagnostic Approaches to Identify Disseminated Ureaplasma urealyticum Infection Causing Hyperammonemia Syndrome After Heart-Kidney Transplant
29. Dual RVAD-ECMO Circuits to Treat Cardiogenic Shock and Hypoxemia Due to Necrotizing Lung Infection: A Case Report
30. Restoring sinus rhythm in a patient with atrial flutter and left ventricular assist device: does it really matter?
31. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy
32. The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis
33. Updates on the Genetic Paradigm in Heart Failure
34. Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis
35. Pulsatile Pressure Delivery of Continuous-Flow Left Ventricular Assist Devices is Markedly Reduced Relative to Heart Failure Patients
36. Interventricular-Septal Output While Supported on Left Ventricular Assist Device Therapy
37. Right atrial lead fixation type and lead position are associated with significant variation in complications
38. HAS-BLED and CHA2DS2-VASc Scores as Predictors of Bleeding and Thrombotic Risk After Continuous-Flow Ventricular Assist Device Implantation
39. Left ventricular assist devices: A historical perspective at the intersection of medicine and engineering
40. Cardiac resynchronization therapy response in cardiac sarcoidosis
41. Survival in Elderly Patients Supported With Continuous Flow Left Ventricular Assist Device as Bridge to Transplantation or Destination Therapy
42. Right Ventricular Dysfunction and Long-Term Risk of Sudden Cardiac Death in Patients With and Without Severe Left Ventricular Dysfunction
43. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.
44. PO-06-083 VENTRICULAR ARRHYTHMIC RISK IN CARDIAC SARCOIDOSIS PATIENTS WITH SYSTOLIC HEART FAILURE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
45. Procainamide pharmacokinetics during extracorporeal membrane oxygenation.
46. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis
47. Physiology of Continuous‐Flow Left Ventricular Assist Device Therapy
48. Procainamide pharmacokinetics during extracorporeal membrane oxygenation
49. Liver Dysfunction: Guilty by Association
50. Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.